I read with interest and congratulations the results of "Long-Term 3T MR Angiography Follow-Up after Therapeutic Occlusion of the Internal Carotid Artery to Detect Possible de Novo Aneurysm Formation," 1 as well as the opinion regarding management of internal carotid artery (ICA) aneurysms in this day of new intravascular options. The authors suggest, with accuracy, that no (or little) systematic follow-up data are available on such patients and that publications are anecdotal. We did systematically review our clinical, if not imaging, follow-up experience with therapeutic occlusion of the ICA, with attention to delayed complications of subarachnoid hemorrhage (SAH) and infarct following balloon occlusion of the ICA. 2 Sixty of 62 patients (97%) who survived at least 6 months (mean, 60 months; median, 112 months) were the basis for analysis. We did use MR angiography (MRA) in the follow-up of patients, but not systematically, and with far less than the 3T MRA quality available to de Gast et al. 1 The total follow-up period was 468 patient years. Two SAHs due to de novo anterior communicating aneurysms occurred, and these are mentioned in de Gast's article. between ALS brains and those of controls. Thus, BPF seems to be the most sensitive MR imaging-based biologic marker in this motor neuron disease and has to be further evaluated in a longitudinal design. With respect to the regional distribution of this atrophy, the pattern and extent of volume losses particularly in frontal and temporal areas vary widely among studies within the well-known overlap of ALS and frontotemporal lobar degeneration (FTLD). Even if detailed neuropsychological investigations as a conditio sine qua non in patient characterization were performed, the results would be heterogeneous. In agreement with Mezzapesa et al, 1 Grosskreutz et al 4 .
Even if methodologic factors might be of relevance, such as the smoothing during data preprocessing (the use of 12-mm FWHM 1 versus 6 mm 2 increases the sensitivity and reduces the specificity), the exact patient characterization with respect to the clinical presentation and disease-related factors is of utmost importance. For the white matter, the structural brain alterations along the corticospinal tracts were only observed in 1 study so far. 2 In summary, the morphologic fingerprint of ALS in motor and extramotor brain areas assessable by in vivo 3D MR imaging analysis awaits further investigations in larger homogeneous patient groups; and for the establishment of BPF as a biologic marker at group level, studies in longitudinal design as far as they may be applicable in this rapidly progressive disorder are required.
